MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

A

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

A

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

A

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

A

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

A

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

Search

Fulgent Genetics Inc

Geschlossen

BrancheGesundheitswesen

17.79 -2.84

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

17.7

Max

17.93

Schlüsselkennzahlen

By Trading Economics

Einkommen

9.3M

-6.2M

Verkäufe

4.5M

76M

EPS

0.04

Gewinnspanne

-8.122

Angestellte

1,313

EBITDA

7.1M

-9.9M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+0.78% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

2. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

73M

585M

Vorheriger Eröffnungskurs

20.63

Vorheriger Schlusskurs

17.79

Nachrichtenstimmung

By Acuity

50%

50%

134 / 385 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Fulgent Genetics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Apr. 2025, 15:57 UTC

Wichtige Markttreiber

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

18. Apr. 2025, 20:42 UTC

Akquisitionen, Fusionen, Übernahmen

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18. Apr. 2025, 20:32 UTC

Top News

Trump to Replace Acting IRS Commissioner -- 2nd Update

18. Apr. 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18. Apr. 2025, 19:52 UTC

Market Talk

Correction to Aluminum Fee Rising Slower Than Forecast Article

18. Apr. 2025, 19:40 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18. Apr. 2025, 19:40 UTC

Market Talk

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18. Apr. 2025, 18:51 UTC

Ergebnisse

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18. Apr. 2025, 18:40 UTC

Akquisitionen, Fusionen, Übernahmen

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18. Apr. 2025, 18:29 UTC

Market Talk

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18. Apr. 2025, 18:21 UTC

Top News

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18. Apr. 2025, 17:31 UTC

Top News

Trump to Replace Acting IRS Commissioner -- WSJ

18. Apr. 2025, 17:24 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18. Apr. 2025, 17:22 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18. Apr. 2025, 16:00 UTC

Top News

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18. Apr. 2025, 15:53 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18. Apr. 2025, 15:46 UTC

Ergebnisse

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18. Apr. 2025, 15:10 UTC

Market Talk
Ergebnisse

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18. Apr. 2025, 14:46 UTC

Ergebnisse

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18. Apr. 2025, 14:24 UTC

Market Talk
Ergebnisse

Netflix Still Has Room to Add Subscribers -- Market Talk

18. Apr. 2025, 14:17 UTC

Ergebnisse

Apple Is an Efficiency Champion. This Company Is Closing in on Its Crown. -- Barrons.com

18. Apr. 2025, 13:55 UTC

Top News

EU Delayed Punishing Apple, Meta Just Before Trade Talks Started -- WSJ

18. Apr. 2025, 11:21 UTC

Ergebnisse

Netflix Stock Jumps on Earnings Beat. Why Tariffs Won't Hurt the Streamer. -- Barrons.com

18. Apr. 2025, 11:00 UTC

Top News

Amazon's Vast Empire Gives It a Leg Up in the Trade War -- Heard on the Street -- WSJ

18. Apr. 2025, 11:00 UTC

Top News

Johnson & Johnson Pivots Its AI Strategy -- WSJ

18. Apr. 2025, 10:36 UTC

Top News

Trump Signals China's Xi Has Reached Out About a Trade Deal. Here's the Latest on Tariffs. -- Barrons.com

18. Apr. 2025, 10:26 UTC

Top News

Why World Leaders Are Pulling Their Punches in the Trade War -- Update

18. Apr. 2025, 09:30 UTC

Top News

Now Streaming on Netflix: A Show Where Profits Trump the Trade War -- Heard on the Street -- Update

18. Apr. 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

18. Apr. 2025, 06:52 UTC

Market Talk

Nikkei Rises 1.0%, Led by Pharma, Shipping Stocks -- Market Talk

Peer-Vergleich

Kursveränderung

Fulgent Genetics Inc Prognose

Kursziel

By TipRanks

0.78% Vorteil

12-Monats-Prognose

Durchschnitt 18 USD  0.78%

Hoch 20 USD

Tief 16 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Fulgent Genetics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

0

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

17.655 / 19.08Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

134 / 385 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.